Catalyzing innovative R&D for neglected tropical diseases, malaria, and tuberculosis
WIPO Re:Search is led by the World Intellectual Property Organization (WIPO) in partnership with BVGH and several leading pharmaceutical companies. Consortium membership includes academic and nonprofit research institutions, governmental and non-governmental organizations, and budding biotechnology companies committed to addressing the unmet medical needs of the developing world. Our 90+ Members represent 26 countries from six continents, including 18 African institutions. Download our Member list here.
The aim of the consortium is to accelerate the development of new drugs, vaccines, and diagnostics for neglected tropical diseases, malaria, and tuberculosis. BVGH creates partnerships that connect private industry’s assets and resources to qualified academic and nonprofit researchers with novel product discovery or development ideas.
BVGH’s leadership is critical to the Consortium’s success. As the Partnership Hub Administrator, BVGH proactively examines scientists’ current neglected disease research and proposes novel collaboration opportunities with other Members. BVGH also fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations with clearly-defined roles, responsibilities, and expectations.
Read the most recent news in the WIPO Re:Search Snapshot.
University of Lagos and Stanford University
Fever is a common symptom of patients in Nigeria. While malaria is prevalent in the region, bacteria, viruses, or other parasites can also be the cause. Determining the correct underlying condition is necessary both for patient care and developing a broader understanding of disease burdens and epidemiology across the country. Developing high-quality diagnostics is therefore a critical research and development objective.
Ms. Chika Celen Okangba, a PhD student under Professor Wellington Oyibo at the University of Lagos, recently spent two months at Stanford University working with Dr. Jesse Waggoner in Professor Benjamin Pinsky’s lab to address this need. Dr. Waggoner taught Ms. Okangba how to extract nucleic acids from patient samples and perform RT PCR-based diagnostic assays. These samples, including plasma, serum, urine, and dried blood spots, were obtained from febrile patients in Nigeria. The diagnostic assays determined which of the pathogens common to the region caused the fever.
This collaboration began in October 2013 after BVGH connected the two professors. Professor Pinsky secured a Stanford International Affairs grant to fund Ms. Okangba spending October and November 2014 at his lab. In February 2015, Professor Oyibo visited Professor Pinsky in Palo Alto to continue the project, as well as to discuss publications and applying for joint grants.
If you are interested in becoming a member of the consortium or learning more, please email Katy Graef at email@example.com.